Preview

Medical Immunology (Russia)

Advanced search

Effects of the DEFB1-20G>A and DEFB1-52G>A gene polymorphism on the level of beta 1 defensin (DEFB1) in young adults with community-acquired pneumonias

https://doi.org/10.15789/1563-0625-EOT-2961

Abstract

The purpose of the present study was to evaluate the effect of DEFB1-20G>A and the DEFB1- 52G>A gene polymorphisms on the expression of DEFB1 in military-age patients with a history of communityacquired pneumonia. A survey of 160 unrelated patients of military age (18-20 years), Caucasian origin was carried out. The first group (n = 80) included the patients with COVID-19 infection complicated by mild pneumonia (n = 40) and severe pneumonia (n = 40). The second group was taken for clinical comparison (n = 80) included the patients with acute respiratory infection (ARI) of non-influenza etiology, complicated by mild pneumonia (n = 40) and severe pneumonia (n = 40). The control group consisted of 86 practically healthy men of the same age. Exclusion criteria were as follows: presence of family relations; patients with acute and/or chronic concomitant pathology. Research methods included clinical laboratory techniques (immunological testing of DEFB1 using a set of ELISA reagents Cloud-Clone Corp. (USA); genetic (polymorphism of the DEFB1-20G>A gene, DEFB1-52G>A gene) with standard primer sets of Litech-SNP (Russia); instrumental examination (computed tomography). The studies were carried out upon admission to the hospital. Statistical evaluation was carried out using the IBM SPSS Statistics Version 25.0 software package (IBM, USA). Predominance of -20A- alleles and genotypes was established -20A/A and -52A/A of the DEFB1 gene variants in the patients with development of severe pneumonia associated with COVID-19 infection. There was an increase in the DEFB1 content in the group with COVID-19 infection by 1.1 times compared with the ARI group, and a 1.5-fold increase against the control group. The changed levels of DEFВ1 associated with severity of community-acquired pneumonia were also characterized by its 1.7-fold increase in the group with a severe clinical course in presence of COVID-19 infection, and by 1.2 times in patients with ARI. The DEFB1 concentration increases significantly in the carriers of DEFB1 -20A/A and -52A/A genotypes. In patients of military age with community-acquired pneumonia, an increased concentration of DEFВ1 is registered, with highest values observed in the group with severe pneumonia due to COVID-19. Carriage of -20A/A and -52A/A genotypes of DEFB1 gene is associated with increased contents of DEFB1. Presence of -20A alleles, -20A/A, and -52A/A genotypes of the DEFB1 genes is associated with severe community-acquired pneumonia associated with COVID-19 infection in patients of military age.

About the Authors

B. T. Zagalaev
Chita State Medical Academy
Russian Federation

Zagalaev B.T., Postgraduate Student, Department of Pediatric Infections

Chita, Transbaikal region



N. A. Miromanova
Chita State Medical Academy
Russian Federation

Miromanova N.A., PhD, MD (Medicine), Associate Professor, Head, Department of Pediatric Infections

Chita, Transbaikal region



A. M. Miromanov
Chita State Medical Academy
Russian Federation

Alexander M. Miromanov, PhD, MD (Medicine), Professor, Head, Department of Traumatology and Orthopedy

39a Gorky St Chita, Transbaikal region 672000

Phone: +7 (924) 386-18-16

Fax: +7 (3022) 32-30-58



References

1. Community-acquired pneumonia in adults: Clinical recommendations. Moscow, 2021. 117 p. Available at: https://cr.minzdrav.gov.ru/recomend/654_1. (Access date: February 10, 2024).

2. Kulikov P.V., Zhogolev S.D., Aminev R.M., Zhogolev K.D., Kuzin A.A., Rubova S.R., Gorenchuk A.N., Mikheeva E.A. Epidemiological and etiological characteristics of community-acquired pneumonia in conscripts in the modern period. Comparative evaluation of the effectiveness of pneumococcal vaccines. Zhurnal infektologii = Journal of Infectology, 2019, Vol. 11, no. 2, pp. 116-123. (In Russ.)

3. Mudrov V.A. Statistical analysis algorithms of qualitativefeatures in biomedical researchusing the SPSS software package. Zabaykalskiy meditsinskiy vestnik = Transbaikal Medical Bulletin, 2020, no. 1, pp. 151-163. (In Russ.)

4. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19): Temporary methodological recommendations. Version 18 (10/26/2023). Moscow, 2023, 250 p. Available at: https://static0.minzdrav.gov.ru/system/attachments/attaches/000/064/610/original/ВМР_COVID-19_V18.pdf (Access date: February 10, 2024

5. Salukhov V.V., Haritonov M.A., Ivanov V.V., Zhurkin M.A., Chumak B.A., Nikolaev A.V., Chugunov A.A., Maltseva O.A. Modern Aspects of Etiological Diagnostics, Clinical Picture and Treatment of Severe Community-Acquired Pneumonia in Soldiers. Vestnik Rossiyskoy voenno-meditsinskoy akademii = Bulletin of the Russian Military Medical Academy, 2020, Vol. 22, no. 1, pp. 45-52. (In Russ.)

6. Kharitonov M.A., Salukhov V.V., Kryukov E.V., Patsenko M.B., Rudakov Yu.V., Bogomolov A.B., Ivanov V.V., Minakov A.A. Viral pneumonia: a new look at an old problem (review). Meditsinskiy Sovet = Medical Council, 2021, no. 16, pp. 60-77. (In Russ.)

7. Farag A.G.A., Shoeib M.A.A., Labeeb A.Z., Sleem A.S., Khallaf H.M.A., Khalifa A.S., Elshaib M.E., Elnaidany N.F., Hanout H.M.A. Human beta-defensin 1 circulating level and gene polymorphism in non-segmental vitiligo Egyptian patients. An. Bras. Dermatol., 2023, Vol. 98, no. 2, pp. 181-188.

8. Holly M.K., Diaz K., Smith J.G. Defensins in viral infection and pathogenesis. Annu. Rev. Virol., 2017, Vol. 4, no 1, рр. 369-391.

9. Inui S., Fujikawa A., Jitsu M., Kunishima N., Watanabe S., Suzuki Y., Umeda S., Uwabe Y. Chest CT findings in cases from the cruise ship diamond princess with coronavirus disease (COVID-19). Radiol. Cardiothorac. Imaging, 2020, Vol. 2, no. 2, e200110. doi: 10.1148/ryct.2020200110.

10. Kirst M.E., Baker D., Li E., Abu-Hasan M., Wang G.P. Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation. PLoS One, 2019, Vol. 14, no. 9, e0222323. doi: 10.1371/journal.pone.0222323.

11. Leiva-Juárez M.M., Kolls J.K., Evans S.E. Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense. Mucosal Immunol., 2018, Vol. 11, no. 1, pp. 21-34.

12. Ochoa-Ramírez L.A., Becerra-Loaiza D.S., Díaz-Camacho S.P., Muñoz-Estrada V.F., Ríos-Burgueño E.R., Prado-Montes de Oca E., Rangel-Villalobos H., Velarde-Félix J.S. Association of human beta-defensin 1 gene polymorphisms with nonsegmental vitiligo. Clin. Exp. Dermatol., 2019, Vol. 44, no. 3, pp. 277-282.

13. Polesello V., Zupin L., Di Lenarda R., Biasotto M., Pozzato G., Ottaviani G., Gobbo M., Crovella S., Segat L. DEFB1 polymorphisms and salivary hBD-1 concentration in oral lichen planus patients and healthy subjects. Arch. Oral. Biol., 2017, Vol. 73, pp. 161–165.

14. Salem R.M., Abdelrahman A.M.N., Abd El-Kareem H.M., Seif M. DEFB1 gene polymorphisms modify vitiligo extent and response to NB-UVB phototherapy. Dermatol. Ther., 2021, Vol. 34, no. 3, e14921. doi: 10.1111/dth.14921.

15. Sharma L., Feng J., Britto C.J., Dela C.C.S. Mechanisms of epithelial immunity evasion by respiratory bacterial pathogens. Front. Immunol., 2020. Vol. 11, 91. doi: 10.3389/fimmu.2020.00091.


Supplementary files

Review

For citations:


Zagalaev B.T., Miromanova N.A., Miromanov A.M. Effects of the DEFB1-20G>A and DEFB1-52G>A gene polymorphism on the level of beta 1 defensin (DEFB1) in young adults with community-acquired pneumonias. Medical Immunology (Russia). 2025;27(1):207-214. (In Russ.) https://doi.org/10.15789/1563-0625-EOT-2961

Views: 2920


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)